Dr. Eugenia O’Kelly is a researcher and engineer dedicated to improving and saving lives through the better design of technology for high-risk systems. She holds a doctorate in engineering from the University of Cambridge and a bachelor’s degree from Stanford University. Her pioneering research has shaped global health policy, informing guidance from the CDC and WHO, and has been featured in leading media outlets including The Guardian, The New York Times, CNN, and The Wall Street Journal.
Dr. O’Kelly’s work spans research, advising, and product development across both civilian and military domains. She has consulted with the U.S. Marine Corps and U.S. Special Operations Command on military medical technology and advised private companies on the design of innovative medical tools. During the COVID-19 pandemic, she led an international task force on infection control, contributing significantly to global public health efforts. Her career reflects a deep commitment to advancing safety, resilience, and innovation in the systems we rely on most.
In every safety critical field—from aviation to nuclear energy—managing risk is paramount. But one domain stands out in both its complexity and its challenge: healthcare. Despite decades of investment, training, and research, adverse outcomes in medicine remain alarmingly common. Why is this? What makes healthcare risk difficult to manage compared to risk in other safety-critical industries?
The word "risk" is everywhere – but how should risk be defined? Many definitions of risk focus on probability, with the implication that risk is an absolute value. Yet, as Professor Terje Aven from the University of Stavanger, Norway, argues, risk is highly subjective. In this article, we will explore Dr Aven’s definition of risk and the role of stakeholder values in determining risk.
An overview of emerging trends in risk management that organizations should monitor.
Guidelines for implementing effective risk management frameworks in organizations.